‘Small molecules are sexy again’: Gate Bioscience debuts with $60M and a new way to stop disease-causing proteins

Gate Bioscience has raised $60 million to develop a new type of pill-based medicine — which it calls a molecular gate — that can go after the spectrum of malicious proteins.

Pat Sharp

The Brisbane, CA biotech was started in 2021 by Jordi Mata‐Fink, a…
Click here to view original post